Clinical Trial Update: Study to Compare the Effect of Valsartan vs Atenolol on Pro-thrombotic State in Hypertensive Patients. [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing valsartan to atenolol to assess their impact on pro-thrombotic state in hypertensive patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• Atenolol (Atenolol)
• VALSARTAN (Valsartan)

Snippet

Sponsor: Novartis | Conditions: Hypertension | Phase 4 | Status: COMPLETED